DK0451486T3 - Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T - Google Patents

Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T

Info

Publication number
DK0451486T3
DK0451486T3 DK91103055.9T DK91103055T DK0451486T3 DK 0451486 T3 DK0451486 T3 DK 0451486T3 DK 91103055 T DK91103055 T DK 91103055T DK 0451486 T3 DK0451486 T3 DK 0451486T3
Authority
DK
Denmark
Prior art keywords
antibiotic
factors
medicaments
directed
treatment
Prior art date
Application number
DK91103055.9T
Other languages
Danish (da)
English (en)
Inventor
Enrico Selva
Maurizio Denaro
Paolo Tavecchia
Ermenegildo Restelli
Pietro Ferrari
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of DK0451486T3 publication Critical patent/DK0451486T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91103055.9T 1990-03-08 1991-03-01 Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T DK0451486T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90104409 1990-03-08
EP90120214 1990-10-22

Publications (1)

Publication Number Publication Date
DK0451486T3 true DK0451486T3 (da) 1995-05-08

Family

ID=26125004

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91103055.9T DK0451486T3 (da) 1990-03-08 1991-03-01 Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T

Country Status (11)

Country Link
US (2) US5747295A (de)
EP (1) EP0451486B1 (de)
JP (1) JP3107584B2 (de)
KR (1) KR0165684B1 (de)
AT (1) ATE121459T1 (de)
CA (1) CA2037779C (de)
DE (1) DE69108972T2 (de)
DK (1) DK0451486T3 (de)
ES (1) ES2071143T3 (de)
GR (1) GR3015899T3 (de)
IE (1) IE67973B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0529410T3 (da) * 1991-08-30 1998-05-11 Biosearch Italia Spa Antibiotikum GE 2270 faktor C2a
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
JPH10508476A (ja) * 1994-11-08 1998-08-25 グルポ・レペチツト・エス・ピー・エイ 抗生物質ｇｅ２２７０因子ｄ▲下２▼を得るための微生物変換法
WO1996024608A1 (en) * 1995-02-07 1996-08-15 Biosearch Italia S.P.A. Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
DE69600244T2 (de) * 1995-02-07 1998-10-01 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
ES2186866T3 (es) * 1996-02-14 2003-05-16 Biosearch Italia Spa Derivados de factores del antibiotico ge2270.
DE102004031656A1 (de) * 2004-06-30 2006-01-19 Merck Patent Gmbh Tetrahydrochinoline
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
BRPI0720542A2 (pt) * 2006-12-20 2014-01-21 Novartis Ag Compostos antibacterianos e processos para a sua produção
CN101772506B (zh) * 2007-06-04 2014-02-12 诺华股份有限公司 大环化合物及其用途
EP2229386B1 (de) 2007-12-12 2015-06-03 Novartis AG Ein aminothiazol derivat und seine verwendung als antibakterieller wirkstoff

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399247A1 (fr) * 1977-08-04 1979-03-02 Rhone Poulenc Ind Antibiotique 35665 rp, sa preparation et les compositions qui les contiennent
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
DE69016284T2 (de) * 1989-07-04 1995-05-24 Lepetit Spa Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DK0529410T3 (da) * 1991-08-30 1998-05-11 Biosearch Italia Spa Antibiotikum GE 2270 faktor C2a
ES2186866T3 (es) * 1996-02-14 2003-05-16 Biosearch Italia Spa Derivados de factores del antibiotico ge2270.

Also Published As

Publication number Publication date
EP0451486B1 (de) 1995-04-19
KR910016938A (ko) 1991-11-05
JPH04217988A (ja) 1992-08-07
US5747295A (en) 1998-05-05
GR3015899T3 (en) 1995-07-31
IE67973B1 (en) 1996-05-15
JP3107584B2 (ja) 2000-11-13
EP0451486A1 (de) 1991-10-16
DE69108972D1 (de) 1995-05-24
IE910754A1 (en) 1991-09-11
CA2037779C (en) 2002-11-05
DE69108972T2 (de) 1995-10-19
ES2071143T3 (es) 1995-06-16
US5843890A (en) 1998-12-01
CA2037779A1 (en) 1991-09-09
KR0165684B1 (ko) 1999-01-15
ATE121459T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
DE69224027D1 (de) Bisaminierte Zyklohexapeptide
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
DK0675900T3 (da) Antibiotika GE 37468 A, B og C
NO911798L (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
EP0359062A3 (de) Antibiotikum GE 2270
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ATE117725T1 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
FI900379A7 (fi) Uudet farmaseuttiset seokset ja uudet farmaseuttiset tuotteet, jotka sallivat leukosyyttien regeneroimisen ja niiden käyttö AIDS:in hoidossa
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms